Trial intelligence / Profile preview

Bupivacaine with versus without adrenaline for paracervical block during cervical conisation under general anesthesia

2014-004504-29Phase 4Completed

Sponsor
Helse Fonna
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine + epinephrine and Marcain in cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by Helse Fonna. Primary endpoints: Increase in blood pressure and Increase in cardiac output. Started Oct 2014; status: completed.

02

Drugs

bupivacaine + epinephrineMarcain
03

Conditions

cervical intraepithelial neoplasia (CIN)

Beyond the preview

Go deeper on 2014-004504-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004504-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call